ライフサイエンスコーパス: licensure

1 prescribed medication in the 30 days before licensure.

2 if they possess properties required for drug licensure.

3 nd to detect potential changes since vaccine licensure.

4 ing exposure during their first 18 months of licensure.

5 for designing phase III trials and ultimate licensure.

6 B vaccines currently under consideration for licensure.

7 and are used to specify criteria for vaccine licensure.

8 , as no current vaccine candidate is nearing licensure.

9 zed to identify changes occurring after MCV4 licensure.

10 ne effectiveness, and regulatory pathways to licensure.

11 ations arise in clinical trials or following licensure.

12 , and/or being prescribed ADHD medication at licensure.

13 without hemophilia has been increasing since licensure.

14 only to meet the visual acuity criteria for licensure.

15 ntil larger population exposures occur after licensure.

16 ameliorate viremia merits consideration for licensure.

17 d be evaluated in efficacy trials to support licensure.

18 eiving US Food and Drug Administration (FDA) licensure 2005-2012 inclusive in seven neurological diso

19 s of HZ vaccine in healthy adults before its licensure, a series of strategies are proposed for evalu

20 provided efficacy data in support of vaccine licensure.A ZIKV CHIM could be instrumental in determini

21 d adult for a full year; followed by level 2 licensure, allowing unsupervised driving from 5 AM to 9

22 (CNC) rates during their first 18 months of licensure and (2) faster reduction in CNC rates over tim

23 Between licensure and April 1999, the FDA received 15 reports of

24 However, the result of more uniform licensure and credentialing may be excessive standardiza

25 Since the licensure and generalization of an effective measles vir

26 ed States during the 25 years before vaccine licensure and identified 2262 people who died with varic

27 Pre-licensure and post-licensure studies have provided data

28 ns concerning advance directives and medical licensure, and literature concerning the fiduciary oblig

29 (26%) disclosed information about clinician licensure, and some used internationally based physician

30 Using this rule, pathways to licensure are being developed for new vaccines against b

31 t that current vision screening for drivers' licensure, based primarily on visual acuity, may miss im

32 o detect potential risks not observed before licensure because of the relatively small sample size an

33 ng boards, resident education accreditation, licensure boards, and hospital medical staff offices.

34 to the needs of payers and credentialing and licensure bodies and to demonstrate dermatologic value.

35 Pre-licensure clinical studies showed that mean serum anti-V

36 the second vaccine dose per US and European licensure criteria in the per-protocol cohort (n = 389).

37 overall (n=113), European influenza vaccine licensure criteria were fulfilled for responses to A/tur

38 logics Evaluation Research and Review (CBER) licensure criteria were met for all groups.

39 >/=70%, thus fulfilling the US and European licensure criteria.

40 Cross-sectional study using physician licensure data linked with administrative records on all

41 re within 6-18 months of passing their state licensure exam at the time of survey administration.

42 could feasibly complete both parts of their licensure examination between May 2007 and March 2011.

43 Adjustment for medical licensure examination scores did not substantially alter

44 potentially adopting a USA based approach to licensure examinations and implementing necessary instit

45 ascertain immunological non-inferiority for licensure for alternate dosing schedules, bridging to ag

46 Efficacy trials that have led to licensure for cervical cancer prevention have used the d

47 nsing (GDL) systems allow full, unrestricted licensure for drivers younger than 18 years only after a

48 s are expected in the near future, including licensure for use in boys and men and the approval of a

49 onjugate vaccine (PCV13) was inferred before licensure from an aggregate correlate of protection esta

50 nce has declined following varicella vaccine licensure, herpes zoster (HZ) cases may play a larger ro

51 ng, even if it were not required for driving licensure; however, only 62% reported always wearing the

52 Since its licensure in 1995, the extensive use of varicella vaccin

53 ed Oka strain VZV vaccine (OkaVZV) since its licensure in 1995.

54 in 2009 and mandated for Puerto Rico medical licensure in 2010.

55 Since licensure in the United States, studies have shown that

56 AGE) during the first 10 years since vaccine licensure, including recent evidence from countries with

57 nd regulatory assessment, with a goal toward licensure is critical for these products.

58 petition by promoting the reestablishment of licensure laws in the late 1800s.

59 Licensure laws were almost nonexistent, and any citizen

60 Little is known about how state-level driver licensure laws, such as in-person renewal, vision tests,

61 tering the driver license system, includes 3 licensure levels, each with driving restrictions and req

62 verage and payment policy and concerns about licensure, liability, and other issues.

63 and fines, civil monetary penalties, loss of licensure, loss of staff privileges, and exclusion from

64 After licensure of a conjugate vaccine for invasive pneumococc

65 To support the licensure of a new and safer vaccine to protect people a

66 ying military personnel with development and licensure of an effective tetravalent dengue vaccine a p

67 Key studies that lead to licensure of antiretroviral medications usually involve

68 Licensure of any medical countermeasure may require demo

69 c health responses, including production and licensure of new influenza A (H1N1) 2009 monovalent vacc

70 ese models toward the goal of utility in the licensure of next-generation alphavirus vaccines and the

71 reports to VAERS in the first 2 years after licensure of PCV described generally minor adverse event

72 gy of PPE by MLST in Utah children after the licensure of PCV-7.

73 mmonly present in the United States prior to licensure of PCV-7.

74 ss from clinical development towards product licensure of several programs presents challenges to gen

75 At roughly the same time, licensure of the combined measles-mumps-rubella-varicell

76 These results build on the recent licensure of the European gene therapy product Glybera f

77 dengue interventions, particularly with the licensure of the first dengue vaccine and promising deve

78 elop safe and effective vaccines resulted in licensure of the first live oral vaccine, tetravalent, r

79 been slower for humans but 2011 will see the licensure of the first viral-vectored vaccine for humans

80 Since licensure of the human papillomavirus (HPV) vaccine in 2

81 After US licensure of the Merck varicella vaccine for immunocompe

82 sible viral targets have been identified and licensure of the most advanced clinical compounds can be

83 ediatric pneumococcal empyema (PPE) prior to licensure of the pneumococcal conjugate vaccine (PCV-7)

84 sed on background rates assessed prior to US licensure of the RV5 (2001-2005).

85 pneumoniae have serotype 3 infections since licensure of the seven-valent pneumococcal conjugate vac

86 nes against group B streptococcus (GBS), the licensure of these vaccines may have to rely on studies

87 During the first year after US licensure of TIV-HD, no new serious safety concerns were

88 However, while development and licensure of vaccines is a major breakthrough, it repres

89 Before licensure of varicella vaccine in 1995, varicella was a

90 siderations for the clinical development and licensure of Zika vaccine candidates including a discuss

91 serogroup B (4CMenB) vaccine was used before licensure on the basis of special consideration by the F

92 that also comply with state/federal laws for licensure or are certified as an ASC and/or are accredit

93 WHO) prequalified vaccines, registration and licensure pathways, participation in WHO-convened joint

94 More stringent state licensure policies such as vision tests, road tests, and

95 The Post-Licensure Rapid Immunization Safety Monitoring (PRISM) s

96 sk of intussusception in large trials before licensure, recent postlicensure data from international

97 icine components, confusing legal issues and licensure requirements, and poor reimbursement.

98 everal issues such as HIPAA, state and local licensure requirements, credentialing and privileging, s

99 onal education in palliative care as part of licensure requirements.

100 liative care training, certification, and/or licensure requirements; (iv) that public and private pay

101 ility to purchase, possess, register, obtain licensure, retain, and/or carry a firearm of any sort.

102 For vaccine licensure, short-term efficacy was inferred from serum b

103 n product availability due to differences in licensure status as well as prohibitively high costs.

104 Pre-licensure and post-licensure studies have provided data supporting vaccine

105 e settings as anticipated from pre- and post-licensure studies.

106 younger, and biosimilar vaccines, with post-licensure surveillance confirming effectiveness.

107 Post-licensure surveillance is needed to monitor vaccine perf

108 the development of a new vaccine through to licensure takes many years, this leaves Africa vulnerabl

109 d during clinical trials and continued after licensure to fully evaluate the effect of RSV preventive

110 ll as for college or board certification and licensure to practice medicine.

111 ountermeasures against anthrax in support of licensure under the FDA's "Animal Rule." However, a need

112 Licensure was based on immunogenicity data comparing PCV

113 Surveillance studies in the post-licensure years have shown an increase in non-vaccine ty